228 related articles for article (PubMed ID: 18055544)
1. The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
Burt D; Salvidio G; Tarabra E; Barutta F; Pinach S; Dentelli P; Camussi G; Perin PC; Gruden G
Am J Pathol; 2007 Dec; 171(6):1789-99. PubMed ID: 18055544
[TBL] [Abstract][Full Text] [Related]
2. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.
Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Perin PC; Camussi G; Gruden G
Diabetes; 2009 Sep; 58(9):2109-18. PubMed ID: 19587356
[TBL] [Abstract][Full Text] [Related]
3. The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.
Lee EY; Chung CH; Khoury CC; Yeo TK; Pyagay PE; Wang A; Chen S
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F85-94. PubMed ID: 19420107
[TBL] [Abstract][Full Text] [Related]
4. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.
Nam BY; Paeng J; Kim SH; Lee SH; Kim DH; Kang HY; Li JJ; Kwak SJ; Park JT; Yoo TH; Han SH; Kim DK; Kang SW
Apoptosis; 2012 Jan; 17(1):1-13. PubMed ID: 22006533
[TBL] [Abstract][Full Text] [Related]
5. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis.
Segerer S; Cui Y; Hudkins KL; Goodpaster T; Eitner F; Mack M; Schlöndorff D; Alpers CE
J Am Soc Nephrol; 2000 Dec; 11(12):2231-2242. PubMed ID: 11095646
[TBL] [Abstract][Full Text] [Related]
6. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional implications of CCR2 expression on murine alveolar epithelial cells.
Christensen PJ; Du M; Moore B; Morris S; Toews GB; Paine R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L68-72. PubMed ID: 14656700
[TBL] [Abstract][Full Text] [Related]
8. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration.
Hidaka T; Suzuki Y; Yamashita M; Shibata T; Tanaka Y; Horikoshi S; Tomino Y
Am J Pathol; 2008 Mar; 172(3):603-14. PubMed ID: 18245810
[TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α.
Dai Y; Chen A; Liu R; Gu L; Sharma S; Cai W; Salem F; Salant DJ; Pippin JW; Shankland SJ; Moeller MJ; Ghyselinck NB; Ding X; Chuang PY; Lee K; He JC
Kidney Int; 2017 Dec; 92(6):1444-1457. PubMed ID: 28756872
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
13. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis.
Wada T; Furuichi K; Segawa-Takaeda C; Shimizu M; Sakai N; Takeda SI; Takasawa K; Kida H; Kobayashi KI; Mukaida N; Ohmoto Y; Matsushima K; Yokoyama H
Kidney Int; 1999 Sep; 56(3):995-1003. PubMed ID: 10469367
[TBL] [Abstract][Full Text] [Related]
14. Treating crescentic glomerulonephritis by targeting macrophages.
Chen A; Lee K; He JC
Kidney Int; 2022 Dec; 102(6):1212-1214. PubMed ID: 36411015
[TBL] [Abstract][Full Text] [Related]
15. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.
Giunti S; Pinach S; Arnaldi L; Viberti G; Perin PC; Camussi G; Gruden G
Kidney Int; 2006 Mar; 69(5):856-63. PubMed ID: 16518346
[TBL] [Abstract][Full Text] [Related]
16. Podocyte involvement in human immune crescentic glomerulonephritis.
Bariéty J; Bruneval P; Meyrier A; Mandet C; Hill G; Jacquot C
Kidney Int; 2005 Sep; 68(3):1109-19. PubMed ID: 16105041
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
18. Podocyte-Specific Deletion of MCP-1 Fails to Protect against Angiotensin II- or Adriamycin-Induced Glomerular Disease.
Bondi CD; Hartman HL; Rush BM; Tan RJ
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732210
[TBL] [Abstract][Full Text] [Related]
19. The regulation and importance of monocyte chemoattractant protein-1.
Bianconi V; Sahebkar A; Atkin SL; Pirro M
Curr Opin Hematol; 2018 Jan; 25(1):44-51. PubMed ID: 28914666
[TBL] [Abstract][Full Text] [Related]
20. MCP-1 in pleural injury: CCR2 mediates haptotaxis of pleural mesothelial cells.
Nasreen N; Mohammed KA; Galffy G; Ward MJ; Antony VB
Am J Physiol Lung Cell Mol Physiol; 2000 Mar; 278(3):L591-8. PubMed ID: 10710532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
